Bank of New York Mellon Corp Cuts Stake in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Bank of New York Mellon Corp trimmed its stake in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 14.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 226,364 shares of the semiconductor company’s stock after selling 38,432 shares during the quarter. Bank of New York Mellon Corp owned about 0.70% of Axcelis Technologies worth $15,816,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of ACLS. Pacer Advisors Inc. lifted its stake in shares of Axcelis Technologies by 78,037.4% in the 4th quarter. Pacer Advisors Inc. now owns 782,155 shares of the semiconductor company’s stock valued at $54,649,000 after purchasing an additional 781,154 shares in the last quarter. Reinhart Partners LLC. lifted its position in Axcelis Technologies by 50.7% during the fourth quarter. Reinhart Partners LLC. now owns 1,036,112 shares of the semiconductor company’s stock valued at $72,393,000 after buying an additional 348,504 shares in the last quarter. Boston Trust Walden Corp lifted its position in Axcelis Technologies by 61.9% during the fourth quarter. Boston Trust Walden Corp now owns 820,116 shares of the semiconductor company’s stock valued at $57,302,000 after buying an additional 313,689 shares in the last quarter. Royce & Associates LP grew its stake in Axcelis Technologies by 157.1% during the third quarter. Royce & Associates LP now owns 273,671 shares of the semiconductor company’s stock worth $28,694,000 after buying an additional 167,235 shares during the period. Finally, Weiss Asset Management LP acquired a new stake in shares of Axcelis Technologies in the third quarter worth $13,874,000. Institutional investors and hedge funds own 89.98% of the company’s stock.

Analysts Set New Price Targets

ACLS has been the subject of a number of recent analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Axcelis Technologies in a report on Wednesday, February 12th. William Blair downgraded Axcelis Technologies from an “outperform” rating to a “market perform” rating in a research note on Wednesday, February 12th. Finally, Craig Hallum reduced their price target on Axcelis Technologies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Wednesday, January 15th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Axcelis Technologies has a consensus rating of “Hold” and an average price target of $154.00.

Axcelis Technologies Stock Down 4.0 %

Shares of NASDAQ ACLS opened at $57.60 on Wednesday. The business has a fifty day moving average of $65.70 and a two-hundred day moving average of $80.49. The company has a debt-to-equity ratio of 0.04, a quick ratio of 4.05 and a current ratio of 5.41. Axcelis Technologies, Inc. has a 52-week low of $53.67 and a 52-week high of $158.61. The stock has a market cap of $1.85 billion, a PE ratio of 9.37, a PEG ratio of 4.52 and a beta of 1.62.

Axcelis Technologies (NASDAQ:ACLS) last posted its quarterly earnings data on Monday, February 10th. The semiconductor company reported $1.54 earnings per share for the quarter, topping the consensus estimate of $1.25 by $0.29. Axcelis Technologies had a net margin of 19.75% and a return on equity of 21.02%. As a group, equities research analysts expect that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current fiscal year.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.